Editorial: Deciphering and targeting the mTOR pathway in hematologic malignancies

被引：0
|
作者：
Lo Nigro, Luca [1 ]
机构：
[1] Azienda Policlin G Rodol San Marco, Ctr Pediat Hematol Oncol, Head Cytogenet Cytofluorimetr Mol Biol Lab, Catania, Italy
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词：
mTOR - mammalian target of rapamycin; acute leukemias; PTEN (phosphatase and tensin homolog deleted on chromosome 10); Rapalogs; PI3; K/AKT;
D O I：
10.3389/fonc.2023.1293795
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The challenge of targeting Notch in hematologic malignancies
    Tejada, Fiorela N. Hernandez
    Silva, Jorge R. Galvez
    Zweidler-McKay, Patrick A.
    FRONTIERS IN PEDIATRICS, 2014, 2
  • [22] Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
    Kawauchi, Kiyotaka
    Ogasawara, Toshie
    Yasuyama, Masako
    Otsuka, Kuniaki
    Yamada, Osamu
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (09) : 1024 - 1038
  • [23] Targeting the mTOR/AKT/PI3K pathway in paediatric malignancies
    Pearson, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S74 - S74
  • [24] Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?
    Reuter, CWM
    Morgan, MA
    Bergmann, L
    BLOOD, 2000, 96 (05) : 1655 - 1669
  • [25] Targeting mTOR Pathways in Human Malignancies
    Fasolo, Angelica
    Sessa, Cristiana
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (19) : 2766 - 2777
  • [26] Editorial: Measurable residual disease in hematologic malignancies
    Buccisano, Francesco
    Palmieri, Raffaele
    Guzman, Monica L.
    Galimberti, Sara
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Editorial: Rising Stars in Hematologic Malignancies 2021
    Qian, Liren
    De Lima, Marcos
    Mims, Alice S.
    Epperla, Narendranath
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Targeting mTOR pathway in gynecological malignancies: Biological rationale and systematic review of published data
    Kassem, Loay
    Abdel-Rahman, Omar
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 108 : 1 - 12
  • [29] The rise of apoptosis: targeting apoptosis in hematologic malignancies
    Valentin, Rebecca
    Grabow, Stephanie
    Davids, Matthew S.
    BLOOD, 2018, 132 (12) : 1248 - 1264
  • [30] Targeting the process of farynesylation for therapy of hematologic malignancies
    Karp, JE
    Lancet, JE
    CURRENT MOLECULAR MEDICINE, 2005, 5 (07) : 643 - 652
12345